Skip to main content

Table 2 Patient characteristics related to first intake of dabigatran

From: Safety and efficacy of switching from low molecular weight heparin to dabigatran in patients undergoing elective total hip or knee replacement surgery

 

THR

TKR

Total

Treated

81

87

168

Time from last enoxaparin to first dose dabigatran (hours)

   

N

79

82

161

Median (Q1, Q3)

24.0 (24.0, 24.0)

24.0 (24.0, 24.0)

24.0 (24.0, 24.0)

Minimum

9

4

4

Maximum

48

48

48

Time from last enoxaparin to first oral dose class (n [%])

   

0 – <14 hours

2 (2.5)

6 (7.3)

8 (5.0)

14 – <22 hours

4 (5.1)

2 (2.4)

6 (3.7)

22 – <26 hours

65 (82.3)

59 (72.0)

124 (77.0)

≥26 hours

8 (10.1)

15 (18.3)

23 (14.3)

Missing

2 (2.5)

5 (5.7)

7 (4.2)

Time to first oral dose after end of surgery (hours)

   

N

79

83

162

Median (Q1, Q3)

35.0 (31.3, 101.7)

33.6 (29.0, 99.3)

34.3 (29.8, 99.5)

Time to first oral dose after end of surgery class

   

Prior to end of surgery

0

0

0

0 – <1 hours

1 (1.2)

0

1 (0.6)

1 – <4 hours

4 (4.9)

5 (5.7)

9 (5.4)

4 – <8 hours

0

3 (3.4)

3 (1.8)

8 – <24 hours

0

0

0

≥24 hours

74 (91.4)

75 (86.2)

149 (88.7)

Missing

2 (2.5)

4 (4.6)

6 (3.6)

Relationship of first dabigatran dose to date of discharge (n [%])

   

1 or more days before discharge

68 (84.0)

67 (77.0)

135 (80.4)

On day of, or 1 day after, discharge

10 (12.3)

10 (11.5)

20 (11.9)

Missing

3 (3.7)

10 (11.5)

13 (7.7)

  1. Q Quartile